SJS Investment Consulting »

Crispr Therapeutics shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2024-03-31 $28k 414 68.16
2023-12-31 $26k 414 62.60
2023-09-30 $18k 404 45.39
2023-06-30 $1.9k 34 56.15
2023-03-31 $1.5k 34 45.24
2022-12-31 $1.4k 34 40.65
2022-09-30 $2.0k 34 58.82
2022-03-31 $2.0k 35 57.14
2021-12-31 $3.0k 34 88.24